The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Not great..but at least Harald lying face who was ramping this previously on twitter got out with his 2%
anything russian ive invested in has always ended up delisting
Well that was a kick in the ****** this morning although on 2nd reading it didn't sound as bad albeit SP reaction won't be pretty :-(
Wish I knew the timeline for drug approvals in Russia! Its been a year this month since applied for so hopefully not to long to go before we find out if we make more money or loose!
coud of been a sell, which is why we are down to 13p on the bid price
Nice 200k buy showing.
Would have been nice if they had gave some sort of timescale for the Oz and NZ trials and also the length of time it takes for an approval/denial in Russia to some, its good that they use the sales of the Poly shares to cover costs which should last quite a while yet and the approval/denial in Russia will be known well before money becomes an issue.
Cracking update and plenty in the pipeline..under the radar is an understatement!!
Market was expecting Russian approval for this drug, company has not said anything about time frame so may be there is slight delay or it could land at anytime.Without that news I dont see anything moving this price up and down.
Self funded through the sale of POLY shares! No placings! Plus an in demand product, yet it remains off the radar
Basically buying the company for free around this sp considering the cash and investment.
Can’t see it hanging around down here when people cotton on.
Nai/DYOR
Steady as she goes, POLY shares were £16.50 on 30th June and they sold a further 209,000 at around £20 in July and August so worth another 1p on the share price.
And they highlight the fact that after you allow for cash and the investment in POLY, you are getting the company basically for free.
Nai/DYOR
Accmmating , we will find out soon.
Interesting
Can see a 30p year when results get announced this month!!
Shares in POLY and cash are worth more than current market cap and they are at a conference next three days !
Nai/DYOR
True I can just imagine those creatures on loose women talking about it! lol
Moves quickly on just a little bit of volume
Small free-float massive potential.
OVB are at an event this week starting tomorrow. Maybe some interest or some news alongside it ?
Results are due this month and could come at anytime. Couldn’t buy many shares yesterday.
https://ovocabio.com/events/
Nai/DYOR
Finished blue 5% up we'll take that.
Just looking at OVB and it seems very undervalued. One of those companies that is worth more than what it's valuation is!
I'm dipping my toe in today and will add on weakness. GLA.
We may something about Drug approval as company said that normal time frame is 12 months and they did submit it in September last year unless Covid 29 delays it.
Always come mid to late September so should get an rns soon. OVB sometimes release DNS’s through the day also so wouldn’t bank on a 7am rns.
Free punt at the minute as cash and POLY shares are worth more than the current market cap.
You get a drug that could be worth hundreds of £millions in for free.
Nai/DYOR
Will bob along awaiting the big catalyst.when approved this will gain huge attention.Very happy to sit on this one no brainer.